Home
Clinical Management
Use Clinical to record your consultations with a patient and their clinical details.
Prescribing
Use Prescribing to prescribe medications to your patient, conforming with all requirements and regulations.
Active Ingredient Prescribing (AIP)
Prescriptions created in MedicalDirector Clinical meet the requirements of the Active Ingredient Prescribing legislation (2019).
3. Guidelines for Active Ingredient Prescribing
These guidelines will assist prescribers in making appropriate clinical decisions for sepcifying a brand name rather than an active ingredient.
3.1 List of Medicines for Brand Consideration - (LMBC)
The LMBC identifies medicines for which prescribers should consider if the inclusion of the brand name on the prescription is necessary for their patient.

Clinical Management
Use Clinical to record your consultations with a patient and their clinical details.
- Diagnosis Coder
  Use the Diagnosis Coder to associate free-text entries with supplied DOCLE text entries.
- Actions
- Progress Notes
- Prescribing
  Use Prescribing to prescribe medications to your patient, conforming with all requirements and regulations.
  - Creating New Prescriptions
    Use Clinical to write prescriptions.
  - Influenza Vaccinations
  - Drug Interaction Checking
  - Old Scripts
  - Managing and Modifying Current Prescriptions
  - Paperless Electronic Prescribing
  - PBS/RPBS Restricted Benefit Medications
  - Printing Batches of Scripts
  - Drug Protocols
  - Drug Quantity, Duration, and Repeats
  - Prescriptions - Real Time Prescription Monitoring
  - Route of Administration
  - Stored Text (Clinical Glossary)
  - User Defined Preparations (Recipes)
  - Active Ingredient Prescribing (AIP)
    Prescriptions created in MedicalDirector Clinical meet the requirements of the Active Ingredient Prescribing legislation (2019).
    - 1. Inclusion of the Brand as a default is prohibited under legislation
    - 2. Exemptions
    - 3. Guidelines for Active Ingredient Prescribing
      These guidelines will assist prescribers in making appropriate clinical decisions for sepcifying a brand name rather than an active ingredient.
      - 3.1 List of Medicines for Brand Consideration - (LMBC)
        The LMBC identifies medicines for which prescribers should consider if the inclusion of the brand name on the prescription is necessary for their patient.
        i. Prescriber selects the drug by Active Ingredient:
        ii. Prescriber selects the drug by the brand:
      - 3.2 List of Excluded Medicinal Items (LEMI)
        The LEMI identifies drugs which are excluded under the AIP legislation from the mandated requirement to include the active ingredient names(s) on the prescription and which therefore may be prescribed by the brand name only.
    - 4. Situations excluded under the AIP Legislations (LEMI)
    - 5. Re-Prescribe or Duplicate Script Functions
    - 6. References
      This option allows you to nominate a specific drug to which the patient is allergic.
- Recalls
- Patient's Medical History
- Investigations
- Immunisations
  Use the Imm. tab to manage a patient's immunisations.
- Preventive Health
  The Preventive Health module provides assistance in identifying and preventing issues and potential problems by making suggestions or recommending actions.
- Assessments
- Cervical Screening
- Obstetrics Module
- Diabetes Module
- Summaries
  Clinical provides ormatted summaries which can be printed for patients.
- Measurements
  The Clinical measurements window displays the history of a patient's various clinical measurements.
- MedicalDirector Care
  Create Care Plans in MedicalDirector.
- Telehealth
  Consult with patients remotely.
- Honeysuckle Health Private Health Insurance Checker
- Tools
- Importing Clinical Data
- Surgical Audit Tool
  Use the Surgical Audit Tool to record information about surgical procedures.

3.1 List of Medicines for Brand Consideration - (LMBC)

The LMBC identifies medicines for which prescribers should consider if the inclusion of the brand name on the prescription is necessary for their patient.

The presence of a drug on the RLDBI is intended as a guide only. It is not used as an absolute dictum which prescribers must follow noting that the inclusion of the brand name may apply to any drug and will be driven by the prescriber implementing a decision based upon the appropriate clinical outcome for the patient.

Considerations for prescribing RLDBI Drugs, where an RLDBI item has been selected:

and the prescriber has NOT intentionally nominated a brand
and the prescriber has not been previously prompted during this prescribing event to consider including a brand,

the software may prompt the prescriber to consider if the inclusion of the brand name on the prescription is necessary for the clinical treatment of their patient.